Could cause temporary or reversible harm; serious harm is unlikely.
Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.
| Brand name | ADVIL ALLERGY AND CONGESTION RELIEF |
| Generic name | CHLORPHENIRAMINE MALEATE, IBUPROFEN, AND PHENYLEPHRINE HYDROCHLORIDE |
| Active ingredient(s) | CHLORPHENIRAMINE MALEATE, IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE |
| Distributed by / for | Glaxosmithkline Consumer Healthcare Holdings |
| NDC | 0573-0196-10 |
| Full product label | Ibuprofen 200 mg Chlorpheniramine Maleate 4mg Phenylephrine 10 mg tablets. Advil Allergy & Congestion Relief 10 and 20 count blister tray in carton NDC 0573-0196-10, item # F00573019610C, 10 ct. blister NDC 0573-0196-20, item # F00573019620C, 20 ct. blister NDC 0573-0196-10, item # F00573019610R, 10 ct. blister |
| Recalling firm | Glaxosmithkline Consumer Healthcare Holdings |
| Distribution | Product was distributed throughout the United States, including Puerto Rico. |
| Quantity | 471,024 blisters |
| Recall initiated | 2020-03-16 |
| Report date | 2020-04-01 |
| Recall completed | 2021-10-28 |
| Recall number | D-1065-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗